2024-511814-20-00招募中1 期
A Phase Ib Safety, Pharmacokinetics and Pharmacodynamics Study of TU7710 in Patients with Haemophilia A or B
Tiumbio Co. Ltd.11 个研究点 分布在 4 个国家目标入组 21 人开始时间: 2024年7月8日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 发起方
- 入组人数
- 21
- 试验地点
- 11
研究概览
简要总结
暂无简介。
入排标准
- 年龄范围
- 18 years 至 65+ years（18-64 Years, 65+ Years）
- 性别
- Male
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
研究者
Heeyeon Jung
Scientific
Tiumbio Co. Ltd.
研究点 (11)
Loading locations...
相似试验
招募中
2 期
A Phase 1/2a Study of Safety, Pharmacokinetics and Neutralizing Activity of SPK002 as pre-exposure prophylaxis of COVID-19 in healthy volunteers (Phase 1) and immunocompromised individuals (Phase 2a).2023-505279-62-00Spikimm78
招募中
1 期
Safety, pharmacokinetics and pharmacodynamics study of Leucettinib-21 in healthy subjects, Down Syndrom and Alzheimer patients2023-507075-22-00Eurofins Optimed, Perha Pharmaceuticals120
招募中
1 期
A Study to Evaluate Single and Multiple Doses of TLC-1180 in Healthy SubjectsNCT07300189OrsoBio, Inc332
招募中
1 期
Phase I Study of CPD704 Inhalation Suspension in Healthy SubjectsNCT07301203Beijing Tide Pharmaceutical Co., Ltd90
暂停
1 期
A 52-week, Phase 1 Safety, Pharmacokinetic and Pharmacodynamic Study of Siplizumab in Newly Diagnosed Adult Amyotrophic Lateral Sclerosis (ALS) Patients (AURORA)2023-506174-12-00Itb-Med AB48